China’s drugmakers can’t sell mRNA shots but haven’t quit yet
By Andrew Silver SHANGHAI/SUZHOU, China (Reuters) – China’s vaccine developers stuck with unused mRNA COVID shots and idle manufacturing plants are pursuing new targets for …
drugmakers
China drugmakers axe IPO plans as they face scrutiny in anti-graft drive
By Jason Xue and Tom Westbrook SHANGHAI (Reuters) – A growing number of healthcare companies in China are shelving their initial public offering (IPO) plans …
Drugmakers set strategy for legal fight against US pricing regulation
By Patrick Wingrove and Michael Erman (Reuters) – Some of the world’s biggest drugmakers are laying legal groundwork to fight the U.S. plan to negotiate …
Drugmakers propose swift pandemic response benefiting poorer countries
FRANKFURT – Global drugmakers are lobbying for wealthy nations to fund a supply mechanism that would secure vaccines for low-income countries without delay in case …
Russia says medicine production stable as drugmakers pull out -RIA
– Russian Health Minister Mikhail Murashko on Thursday said the situation with medicines was stable in Russia and that all producers were continuing to work, …
U.S. should review drugmakers’ opioid settlement tax breaks – House panel
WASHINGTON – The U.S. Justice and Treasury Departments should review the tax deductions four drugmakers made related to their $26 billion opioid settlement, the U.S. …